Limited sampling strategies for individualized BAX 855 prophylaxis in severe hemophilia A: in silico evaluation

por Bukkems, Laura H., Goedhart, Tine M.H.J., Zwaan, C. Michel, Cnossen, Marjon H., Mathôt, Ron A.A.
Publicado 2023

Population pharmacokinetic modeling of factor concentrates in hemophilia: an overview and evaluation of best practice

por Goedhart, Tine M. H. J., Bukkems, Laura H., Zwaan, C. Michel, Mathôt, Ron A. A., Cnossen, Marjon H.
Publicado 2021

Marfan syndrome in adolescence: adolescents’ perspectives on (physical) functioning, disability, contextual factors and support needs

por Warnink-Kavelaars, Jessica, Beelen, Anita, Goedhart, Tine M. H. J., de Koning, Lisanne E., Nollet, Frans, Alsem, Mattijs W., Menke, Leonie A., Engelbert, Raoul H. H.
Publicado 2019

Does difference between label and actual potency of factor VIII concentrate affect pharmacokinetic‐guided dosing of replacement therapy in haemophilia A?

por Goedhart, Tine M.H.J., Bukkems, Laura H., van Moort, Iris, Spence, Colin C., Zwaan, Michel C., de Maat, Moniek P.M., Mathôt, Ron A.A., Cnossen, Marjon H.
Publicado 2022

Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)

por Goedhart, Tine M.H.J., Bukkems, Laura H., Coppens, Michiel, Fijnvandraat, Karin J., Schols, Saskia E.M., Schutgens, Roger E.G., Eikenboom, Jeroen, Heubel-Moenen, Floor C.J.I., Ypma, Paula F., Nieuwenhuizen, L., Meijer, K., Leebeek, Frank W. G., Mathôt, Ron A.A., Cnossen, Marjon H.
Publicado 2022